Abstract
The Nef protein is an essential factor for lentiviral pathogenesis in humans and other simians. Despite a multitude of functions attributed to this protein, the exact role of Nef in disease progression remains unclear. One of its most intriguing functions is the ability of Nef to enhance the infectivity of viral particles. In this review we will discuss current insights in the mechanism of this well-known, yet poorly understood Nef effect. We will elaborate on effects of Nef, on both virion biogenesis and the early stage of the cellular infection, that might be involved in infectivity enhancement. In addition, we provide an overview of different HIV-1 Nef domains important for optimal infectivity and briefly discuss some possible sources of the frequent discrepancies in the field. Hereby we aim to contribute to a better understanding of this highly conserved and therapeutically attractive Nef function.
Keywords: Nef, HIV, infectivity, viral replication, mutation analysis, envelope protein, cholesterol, proteasome, NEF PROTEIN, Domain Mutations
Current HIV Research
Title: The Nef-Infectivity Enigma: Mechanisms of Enhanced Lentiviral Infection
Volume: 9 Issue: 7
Author(s): Jolien Vermeire, Griet Vanbillemont, Wojciech Witkowski and Bruno Verhasselt
Affiliation:
Keywords: Nef, HIV, infectivity, viral replication, mutation analysis, envelope protein, cholesterol, proteasome, NEF PROTEIN, Domain Mutations
Abstract: The Nef protein is an essential factor for lentiviral pathogenesis in humans and other simians. Despite a multitude of functions attributed to this protein, the exact role of Nef in disease progression remains unclear. One of its most intriguing functions is the ability of Nef to enhance the infectivity of viral particles. In this review we will discuss current insights in the mechanism of this well-known, yet poorly understood Nef effect. We will elaborate on effects of Nef, on both virion biogenesis and the early stage of the cellular infection, that might be involved in infectivity enhancement. In addition, we provide an overview of different HIV-1 Nef domains important for optimal infectivity and briefly discuss some possible sources of the frequent discrepancies in the field. Hereby we aim to contribute to a better understanding of this highly conserved and therapeutically attractive Nef function.
Export Options
About this article
Cite this article as:
Vermeire Jolien, Vanbillemont Griet, Witkowski Wojciech and Verhasselt Bruno, The Nef-Infectivity Enigma: Mechanisms of Enhanced Lentiviral Infection, Current HIV Research 2011; 9 (7) . https://dx.doi.org/10.2174/157016211798842099
DOI https://dx.doi.org/10.2174/157016211798842099 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ulcerative Colitis: Pathogenesis
Current Drug Targets Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Clomiphene Citrate, Metformin or Both for Ovulation Induction in Therapy Naïve Women with Polycystic Ovary Syndrome (PCOS)? A Descriptive Review
Current Drug Therapy Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets The Multidomain Mobility Lab in Older Persons: From Bench to Bedside. The Assessment of Body Composition in Older Persons at Risk of Mobility Limitations
Current Pharmaceutical Design Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Therapeutic Potentials of Recently Identified PLD Inhibitors
Current Chemical Biology Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome<sup>#</sup>
Current Pharmaceutical Design Surgical Treatment of Distal Radio-Ulnar Joint (DRUJ) Arthritis
Current Rheumatology Reviews Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets New Insights on the Perturbations of T Cell Cycle During HIV Infection
Current Medicinal Chemistry Skin as a Novel Route for Allergen-specific Immunotherapy
Current Pharmaceutical Design Chondroitin Sulphate for the Treatment of Osteoarthritis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents <i>In Silico</i> Assessment of the Acute Toxicity of Chemicals: Recent Advances and New Model for Multitasking Prediction of Toxic Effect
Mini-Reviews in Medicinal Chemistry Methicillin-Sensitive <i>Staphylococcus aureus</i> Pyogenic Iliopsoas Abscesses: A Case Series from Jodhpur, India
Infectious Disorders - Drug Targets Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Advances and Challenges in Kidney Organoids
Current Stem Cell Research & Therapy NK Cells and HIV Infection: Lessons from other Viruses
Current Molecular Medicine New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Aspects of Antisense Oligodeoxynucleotide, Ribozyme, DNA Enzyme and RNAi Design
Current Medicinal Chemistry - Central Nervous System Agents